FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:508-510 August 17, 2000 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Angell, M. Related Article by Bodenheimer, T. Related Article by Moy, E. PubMed Citation

To the Editor: In her editorial, Dr. Angell (May 18 issue)¹ discusses the increasing ties between academic medical institutions and industry. She notes that the benefit for the former is needed cash and that the benefit for the latter is access to talented researchers. But, in fact, the benefit for industry is access to patients much more than access to talented researchers. If corporations sought access only to talented researchers, they could use promises of better facilities, better support staff, and higher salaries to attract great researchers to their industrial complexes. Industry does not want to buy these researchers outright . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.